Opioid peptide receptor studies. 7. The methylfentanyl congener RTI- 4614-4 and its four enantiomers bind to different domains of the rat μ opioid receptor

Synapse

Volumn 28, Issue 2, 1998, Pages 117-124

  Lu, Yi Feng ^a   Xu, Heng ^a   Liu Chen, Lee Yuan ^b   Chen, Chongguang ^b   Partilla, John S ^a   Brine, George A ^c   Carroll, F Ivy ^c   Rice, Kenner C ^d   Lai, Josephine ^e   Porreca, Frank ^e   Sadee, Wolfgang ^f   Rothman, Richard B ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c RTI INTERNATIONAL   (United States)

^d NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^e UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

receptor; (+) 3 methylfentanyl; RTI 4614 4

Indexed keywords

FENTANYL DERIVATIVE; OPIATE PEPTIDE; OPIATE RECEPTOR;

ANIMAL CELL; ARTICLE; DRUG RECEPTOR BINDING; ENANTIOMER; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; STEREOCHEMISTRY;

AFFINITY LABELS; ANALGESICS; ANALGESICS, OPIOID; ANIMALS; BINDING SITES; BINDING, COMPETITIVE; COS CELLS; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; ENKEPHALIN, LEUCINE-2-ALANINE; ENKEPHALINS; ETORPHINE; FENTANYL; MELPHALAN; MEMBRANE PROTEINS; PROTEIN STRUCTURE, TERTIARY; RADIOLIGAND ASSAY; RATS; RECEPTORS, OPIOID, MU; RECOMBINANT FUSION PROTEINS; STEREOISOMERISM;

EID: 6844254562     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2396(199802)28:2<117::AID-SYN2>3.0.CO;2-E     Document Type: Article

References (41)

1. Arden, J.R., Segredo, V., Wang, Z., Lameh, J., and Sadee, W. (1995) Phosphorylation and agonist-specific intracellular trafficking of an epitope-tagged mu-opioid receptor expressed in HEK 293 cells. J. Neurochem., 65:1636-1645.
2. Band, L., Xu, H., Bykov, V., Greig, N., Kim, C.-H., Newman, A., Jacobson, A.E., Rice, K.C., and Rothman, R.B. (1990) The potent opiate agonist, (+)-cis-3-methylfentanyl binds pseudoirreversibly to the opioid receptor complex in vitro and in vivo: Evidence for a novel mechanism of action. Life Sci., 47:2231-2240.
3. Brine, G.A., Stark, P.A., Carroll, F.I., Xu, H., and Rothman, R.B. (1992) Enantiomers of (±)-cis-N-[1-(2-hydroxy-2-phenylethyl)-3-methyl-4-piperidyl]-N- phenylpropanamide: Influence of the hydroxyl group. Med. Chem. Res., 2:34-40.
4. Brine, G.A., Stark, P.A., Liu, Y., Carroll, F.I., Singh, P., Xu, H., and Rothman, R.B. (1995) Enantiomers of diastereomeric cis-N-[1-(2-hydroxy-2-phenylethyl)-3-methyl-4-piperidyl]-N-phenyl propanamide: Synthesis, x-ray analysis, and biological activities. J. Med. Chem., 38:1547-1557.
5. Casy, A.F., and Parfitt, R.T. (1986) Fentanyl and the 4-anilinopiperidine group of analgesics. In: Opioid analgesics. Chemistry and Receptors. Plenum Press, New York, pp. 287-301.
6. 1c serotonin receptors. Mol. Pharmacol., 42:627-633.
7. 125I]Ioxy). J. Med. Chem., 35: 2826-2835.
8. 2 receptor. Mol. Brain Res., 14:166-178.
9. 1a receptors. Mol. Pharmacol., 41:695-698.
10. Jin, W.Q., Xu, H., Zhu, Y.C., Fang, S.N., Xia, X.L., Huang, Z.M., Ge, B.L., and Chi, Z.Q. (1981) Studies on synthesis and relationship between analgesic activity and receptor affinity for 3-methyl fentanyl derivatives. Sci. Sin., 24:710-720.
11. Kao, H.T., Adham, N., Olsen, M.A., Weinshank, R.L., Branchek, T.A., and Hartig, P.R. (1992) Site-directed mutagenesis of a single residue changes the binding properties of the serotonin 5-HT2 receptor from a human to a rat pharmacology. FEBS Lett., 307:324-328.
12. Kayakiri, H., Jacobson, A.E., Rice, K.C., Rothman, R.B., Xu, H., Flippen-Anderson, J., George, C., Aceto, M.D., Bowman, E.R., Harris, L.S., May, E.L., Partilla, J.S., and Becketts, K. (1996) Probes for narcotic receptor mediated phenomena. 24. Synthesis, single crystal x-ray analysis, in vitro and in vivo properties of 6a- and 6b-iodo-3,14-dihydroxy-17-methyl-4,5α-epoxymorphinans. Med. Chem. Res., 6:427-438.
13. Knott, G.D., and Reece, D.K. (1972) MLAB: A civilized curve fitting system. Proceedings of the Online 1972 International Conference, 1:497-526.
14. Kong, H., Raynor, K., Yasuda, K., Bell, G.I., and Reisine, T. (1993a) Mutation of an aspartate at residue 89 in somatostatin receptor subtype 2 prevents Na+ regulation of agonist binding but does not alter receptor-G protein association. Mol. Pharmacol., 44:380-384.
15. Kong, H., Raynor, K., Yasuda, K, Moe, S.T., Portoghese, P.S., Bell, G.I., and Reisine, T. (1993b) Asingle residue, aspartic acid 95, in the delta opioid receptor specifies selective high affinity agonist binding. J. Biol. Chem., 268:23055-23058.
16. Lai, J., Ma, S.W., Zhu, R.H., Rothman, R.B., Lentes, K.U., and Porreca, F. (1994) Pharmacological characterization of the cloned kappa opioid receptor as a kappa 1b subtype. Neuroreport, 5:2161-2164.
17. Leysen, J., Tollenaere, J.P., Koch, M.H., and Laduron, P. (1977) Differentiation of opiate and neuroleptic receptor binding in rat brain. Eur. J. Pharmacol., 43:253-267.
18. 284 of the human δ opioid receptor is required for SNC121 binding but not binding of pCI-DPDPE, deltorphin II or naltrindole. Analgesia, 1:539-542.
19. Lowry, O.H., Rosenbrough, N.H., Farr, A.L., and Randall, P.J. (1951) Protein measurement with the folin phenol reagent. J. Biol. Chem., 193:265-275.
20. Meng, F., Hoversten, M.T., Thompson, R.C., Taylor, L., Watson, S.J., and Akil, H. (1995) A chimeric study of the molecular basis of affinity and selectivity of the kappa and the delta opioid receptors. Potential role of extracellular domains. J. Biol. Chem., 270:12730-12736.
21. Minami, M., Onogi, T., Nakagawa, T., Katao, Y., Aoki, Y., Katsumata, S., and Satoh, M. (1995) DAMGO, a mu-opioid receptor selective ligand, distinguishes between mu- and kappa-opioid receptors at a different region from that for the distinction between mu- and delta-opioid receptors. FEBS Lett., 364:23-27.
22. Neve, K.A., Cox, B.A., Henningsen, R.A., Spanoyannis, A., and Neve, R.L. (1991) Pivotal role for aspartate-80 in the regulation of dopamine D2 receptor affinity for drugs and inhibition of adenyl cyclase. Mol. Pharmacol., 39:733-739.
23. 2a binding sites. Peptides, 14:1279-1294.
24. Ni, Q., Xu, H., Partilla, J.S., Stark, P.A., Carroll, F.I., Brine, G.A., and Rothman, R.B. (1993b) Stereochemical requirements for pseudoirreversible inhibition of opioid mu receptor binding by the 3-methylfentanyl congeners, RTI-4614-4 and its enantiomers: Evidence for different binding domains. Synapse, 15:296-306.
25. O'Dowd, B.F., Hantowich, M., Regan, J.W., Leader, W.M., and Caron, M.G. (1988) Site-directed mutagenesis of the cytoplasmic domains of the human beta-2-adrenergic receptor localization of regions involved in G protein-receptor coupling. J. Biol. Chem., 263:15985-15992.
26. Onogi, T., Minami, M., Katao, Y., Nakagawa, T., Aoki, Y., Toya, T., Katsumata, S., and Satoh, M. (1995) DAMGO, a mu-opioid receptor selective agonist, distinguishes between mu- and delta-opioid receptors around their first extracellular loops. FEBS Lett., 357:93-97.
27. Rodbard, D., Lenox, R.H., Wray, H.L., and Ramseth, D. (1976) Statistical characterization of the random errors in the radioimmunoassay dose-response variable. Clin. Chem., 22:350-358.
28. Rosenbaum, J.S., Holford, N.H., and Sadee, W. (1984) Opiate receptor binding-effect relationship: Sufentanil and etorphine produce analgesia at the mu-site with low fractional receptor occupancy. Brain Res., 291:317-324.
29. 3H]cycloFOXY: An opiate antagonist suitable for positron emission tomography. Biol. Psychol., 23:435-458.
30. Rothman, R.B., Bykov, V., de Costa, B.R., Jacobson, A.E., Rice, K.C., and Brady, L.S. (1990) Interaction of endogenous opioid peptides and other drugs with four kappa opioid binding sites in guinea pig brain. Peptides, 11:311-331.
31. Rothman, R.B., Xu, H., Seggel, M., Jacobson, A.E., Rice, K.C., Brine, G.A., and Carroll, F.I. (1991) RTI-4614-4: An analog of (+)-cis-3-methylfentanyl with a 27,000-fold binding selectivity for mu versus delta opioid binding sites. Life Sci., 48:PL111-PL116.
32. Rothman, R.B., Xu, H., Wang, J.B., Partilla, J.S., Kayakiri, H., Rice, K.C., and Uhl, G.R. (1995) Ligand-selectivity of cloned human and rat opioid mu receptors. Synapse, 21:60-64.
33. Van Bever, W.F.M., Niemegeers, C.J.E., and Janssen, P.A.J. (1974) Synthetic analgesics. Synthesis and pharmacology of the diastereoisomers of N-[3-Methyl- 1-(2-phenylethyl)-4-piperidyl]-N-phenylpropanamide and N-[3-Methyl-1-(1-methyl-2-phenylethyl)-4-piperidyl]-N-phenylpropa namide. J. Med. Chem., 17:1047-1051.
34. Wang, J.-B., Imai, Y., Eppler, C.M., Gregor, P., Spivak, C.E., and Uhl, G.R. (1993) m opiate receptor: cDNA cloning and expression. Proc. Natl. Acad. Sci. U.S.A., 90:10230-10234.
35. Wang, Z.-X., Zhu, Y.-C., Jin, W.-Q., Chen, X.-J., Chen, J., Ji, R.-Y., and Chi, Z.-Q. (1995) Stereoisomers of N-[1(2-hydroxy-2-phenylethyl)-3-methyl-4-piperidyl]-N-phenylpropa namide: Synthesis, stereochemistry, analgesic activity, and opioid receptor binding characteristics. J. Med. Chem., 38:3652-3659.
36. Wilson, R.S., Rogers, M.E., Pert, C.B., and Snyder, S.H. (1975) Homologous N-alkylnorketobemidones. Correlation of receptor binding with analgesic potency. J. Med. Chem., 18:240-242.
37. Xu, H., Yao, Y.H., Zhu, Y.C., Chen, J., and Chi, Z.Q. (1987) Potent 3-methylfentanyl analogs: Morphine-like catalepsy and receptor binding characteristics. Chung Kuo Yao Li Hsueh Pao, 8:289-292.
38. Xu, H., Kim, C.-H., Zhu, Y.C., Weber, R.J., Rice, K.C., and Rothman, R.B. (1991) (+)-cis-methylfentanyl and its analogs bind pseudoirreversibly to the mu opioid binding site: Evidence for pseudoallosteric modulation. Neuropharmacology, 30:455-462.
39. Xue, J.C., Chen, C., Zhu, J., Kunapuli, S., DeRiel, J.K., Yu, L., and Liu-Chen, L.Y. (1994) Differential binding domains of peptide and non-peptide ligands in the cloned rat kappa opioid receptor. J. Biol. Chem., 269:30195-30199.
40. Xue, J.C., Chen, C., Zhu, J., Kunapuli, S.P., de Riel, J.K., Yu, L., and Liu-Chen, L.Y. (1995) The third extracellular loop of the mu opioid receptor is important for agonist selectivity. J. Biol. Chem., 270: 12977-12979.
41. Zhu, G., Wu, L.H., Mauzy, C., Egloff, A.M., Mirzadegan, T., and Chung, F.Z. (1992) Replacement of lysine-181 by aspartic acid in the third transmembrane region of endothelin type b receptor reduces its affinity to endothelin peptides and sarafotoxin 6c without affecting G protein coupling. J. Cell. Biochem., 50:159-164.